Great Tree Pharmacy Co., Ltd. (TPEX:6469)
71.40
+1.30 (1.85%)
May 29, 2026, 1:30 PM CST
Great Tree Pharmacy Revenue
Great Tree Pharmacy had revenue of 4.84B TWD in the quarter ending March 31, 2026, with 3.70% growth. This brings the company's revenue in the last twelve months to 19.07B, up 7.52% year-over-year. In the year 2025, Great Tree Pharmacy had annual revenue of 18.90B with 9.39% growth.
Revenue (ttm)
19.07B
Revenue Growth
+7.52%
P/S Ratio
0.56
Revenue / Employee
42.75M
Employees
446
Market Cap
10.69B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 18.90B | 1.62B | 9.39% |
| Dec 31, 2024 | 17.27B | 1.13B | 7.00% |
| Dec 31, 2023 | 16.14B | 1.58B | 10.84% |
| Dec 31, 2022 | 14.56B | 3.28B | 29.11% |
| Dec 31, 2021 | 11.28B | 2.64B | 30.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 24.42B |
| PharmaEssentia | 17.50B |
| Standard Chemical & Pharmaceutical | 7.03B |
| TaiDoc Technology | 4.30B |
| Universal Vision Biotechnology | 4.17B |
| Vizionfocus | 3.71B |
| Tanvex BioPharma | 483.94M |
| Caliway Biopharmaceuticals | 38.04M |